Skip to main content
Top
Published in: BMC Public Health 1/2018

Open Access 01-12-2018 | Research article

Quit outcomes among clients ineligible for cessation medication through the state quitline: a retrospective, observational study

Authors: Adrienne B. Lent, Patrick A. O’Connor, Ryan C. Reikowsky, Uma S. Nair, Melanie L. Bell

Published in: BMC Public Health | Issue 1/2018

Login to get access

Abstract

Background

Distribution of tobacco cessation medications through state quitlines increases service utilization and quit outcomes. However, some state quitlines have moved to models in which callers are instructed to obtain quit medications through their health insurance pharmaceutical benefit. We aimed to investigate the impact of this policy on medication access and quit outcomes in the state quitline setting for clients who must obtain covered medications through the state Medicaid program. We hypothesized that clients with Medicaid who were referred by their healthcare provider would be more likely to report using quit medication and have higher quit rates compared to clients with Medicaid who engaged the quitline on their own.

Methods

An observational, retrospective study was conducted using state quitline clients with Medicaid health insurance who were ineligible for quitline provided cessation medications. Clients were stratified by referral type: self-referred, passively referred, and proactively referred. Unadjusted and adjusted logistic regression was used to estimate the effect of referral type on both quit status and cessation medication use.

Results

Proactively referred clients were less likely to use quit medication (53.6%) compared to self (56.9%) and passively referred clients (61.1%). Proactively referred clients had lower quit rates (31.4%), as compared to passively referred (36.0%) and self-referred (35.1%). In adjusted models, proactively referred clients were significantly less likely to be quit than passively referred clients (OR = 0.75, 95% CI: 0.56, 0.99). There were no statistically significant differences in medication use or number of coaching sessions among proactive, passive, and self-referred clients in adjusted models.

Conclusions

In adjusted models, medication use did not significantly differ by mode of entry in this population of Medicaid beneficiaries. Psychosocial factors such as intention to quit in the next 30 days, social support for quitting, education level, race, and ethnicity impacted quit status and differed by mode of entry. Quitlines should use tailored strategies to increase engagement and reduce barriers among proactively referred clients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Warren GW, Alberg AJ, Kraft AS, Cummings KM. The 2014 surgeon General’s report: ‘the health consequences of Smoking-50 years of progress’: a paradigm shift in cancer care. Cancer. 2014;120(13):1914–6.CrossRefPubMedPubMedCentral Warren GW, Alberg AJ, Kraft AS, Cummings KM. The 2014 surgeon General’s report: ‘the health consequences of Smoking-50 years of progress’: a paradigm shift in cancer care. Cancer. 2014;120(13):1914–6.CrossRefPubMedPubMedCentral
2.
go back to reference M. Vijayaraghavan, S. A. Schroeder, and M. Kushel, “The effectiveness of tobacco control policies on vulnerable populations in the USA: a review,” Postgrad. Med. J., 2016. M. Vijayaraghavan, S. A. Schroeder, and M. Kushel, “The effectiveness of tobacco control policies on vulnerable populations in the USA: a review,” Postgrad. Med. J., 2016.
3.
go back to reference Jamieson DJ, Uyeki TM, Callaghan WM, Meaney-Delman D, Rasmussen SA. Center for Disease Control and Prevention, “Best Practices for Comprehensive Tobacco Control Programs - 2014”. Obstet Gynecol. 2014;124(5):1005–10.CrossRefPubMed Jamieson DJ, Uyeki TM, Callaghan WM, Meaney-Delman D, Rasmussen SA. Center for Disease Control and Prevention, “Best Practices for Comprehensive Tobacco Control Programs - 2014”. Obstet Gynecol. 2014;124(5):1005–10.CrossRefPubMed
4.
go back to reference Xu X, Bishop EE, Kennedy SM, Simpson SA, Pechacek TF. Annual healthcare spending attributable to cigarette smoking: an update. Am J Prev Med. 2015;48(3):326–33.CrossRefPubMed Xu X, Bishop EE, Kennedy SM, Simpson SA, Pechacek TF. Annual healthcare spending attributable to cigarette smoking: an update. Am J Prev Med. 2015;48(3):326–33.CrossRefPubMed
6.
go back to reference Stead LF, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews. 2012;11(11):CD000146.PubMed Stead LF, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews. 2012;11(11):CD000146.PubMed
7.
go back to reference Cummings KM, Fix B, Celestino P, Carlin-Menter S, O’Connor R, Hyland A. Reach, efficacy, and cost-effectiveness of free nicotine medication giveaway programs. J Public Health Manag Pract. 2006;12(1):37–43.CrossRefPubMed Cummings KM, Fix B, Celestino P, Carlin-Menter S, O’Connor R, Hyland A. Reach, efficacy, and cost-effectiveness of free nicotine medication giveaway programs. J Public Health Manag Pract. 2006;12(1):37–43.CrossRefPubMed
8.
go back to reference Tinkelman D, Wilson SM, Willett J, Sweeney CT. Offering free NRT through a tobacco quitline: impact on utilisation and quit rates. Tob Control. 2007;16:42–6.CrossRef Tinkelman D, Wilson SM, Willett J, Sweeney CT. Offering free NRT through a tobacco quitline: impact on utilisation and quit rates. Tob Control. 2007;16:42–6.CrossRef
9.
go back to reference Hopkins DP, et al. Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke. Am J Prev Med. 2001;20(2S):16–66.CrossRefPubMed Hopkins DP, et al. Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke. Am J Prev Med. 2001;20(2S):16–66.CrossRefPubMed
10.
go back to reference Stead LF, Perera R, Lancaster T. Telephone counselling for smoking cessation. Cochrane Database Syst. Rev. 2006;3(8):CD002850. Stead LF, Perera R, Lancaster T. Telephone counselling for smoking cessation. Cochrane Database Syst. Rev. 2006;3(8):CD002850.
13.
go back to reference Burns EK, Hood NE, Goforth E, Levinson AH. Randomised trial of two nicotine patch protocols distributed through a state quitline. Tob Control. 2016;25(2):218–23.CrossRefPubMed Burns EK, Hood NE, Goforth E, Levinson AH. Randomised trial of two nicotine patch protocols distributed through a state quitline. Tob Control. 2016;25(2):218–23.CrossRefPubMed
14.
go back to reference Cole S, Suter C, Nash C, Pollard J. Impact of a temporary NRT enhancement in a state Quitline and web-based program. Am. J. Health Promot. 2016;32(5):1206–13.CrossRefPubMed Cole S, Suter C, Nash C, Pollard J. Impact of a temporary NRT enhancement in a state Quitline and web-based program. Am. J. Health Promot. 2016;32(5):1206–13.CrossRefPubMed
15.
go back to reference Rhodes KV, et al. Primary care access for new patients on the eve of health care reform. JAMA Intern Med. 2014;174(6):861–9.CrossRefPubMed Rhodes KV, et al. Primary care access for new patients on the eve of health care reform. JAMA Intern Med. 2014;174(6):861–9.CrossRefPubMed
16.
go back to reference Huang ES, Finegold K. Seven million Americans live in areas where demand for primary care may exceed supply by more than 10 percent. Health Aff. 2013;32(3):614–21.CrossRef Huang ES, Finegold K. Seven million Americans live in areas where demand for primary care may exceed supply by more than 10 percent. Health Aff. 2013;32(3):614–21.CrossRef
17.
go back to reference Cokkinides VE, Ward E, Jemal A, Thun MJ. Under-use of smoking-cessation treatments: results from the National Health Interview Survey, 2000. Am J Prev Med. 2005;28(1):119–22.CrossRefPubMed Cokkinides VE, Ward E, Jemal A, Thun MJ. Under-use of smoking-cessation treatments: results from the National Health Interview Survey, 2000. Am J Prev Med. 2005;28(1):119–22.CrossRefPubMed
18.
go back to reference Nair US, Reikowsky RC, Wertheim BC, Thomson CA, Gordon JS. Quit outcomes and program utilization by mode of entry among clients enrolling in a Quitline. Am J Health Promot. 2018;1:890117117749366. Nair US, Reikowsky RC, Wertheim BC, Thomson CA, Gordon JS. Quit outcomes and program utilization by mode of entry among clients enrolling in a Quitline. Am J Health Promot. 2018;1:890117117749366.
20.
go back to reference Pomerleau CS, Carton SM, Lutzke ML, Flessland KA, et al. Reliability of the Fagerström tolerance questionnaire and the Fagerström test for nicotine dependence. Addict. Behav. 1994;19(1):33–9.CrossRefPubMed Pomerleau CS, Carton SM, Lutzke ML, Flessland KA, et al. Reliability of the Fagerström tolerance questionnaire and the Fagerström test for nicotine dependence. Addict. Behav. 1994;19(1):33–9.CrossRefPubMed
21.
go back to reference Fagerström K. Determinants of tobacco use and renaming the FTND to the Fagerström test for cigarette dependence. Nicotine and Tobacco Research. 2012;14(1):75–8.CrossRefPubMed Fagerström K. Determinants of tobacco use and renaming the FTND to the Fagerström test for cigarette dependence. Nicotine and Tobacco Research. 2012;14(1):75–8.CrossRefPubMed
22.
go back to reference Pomerleau CS, Majchrzak MJ, Pomerleau OF. Nicotine dependence and the Fagerstrom tolerance questionnaire: a brief review. J Subst Abus. 1989;1(4):471–7. Pomerleau CS, Majchrzak MJ, Pomerleau OF. Nicotine dependence and the Fagerstrom tolerance questionnaire: a brief review. J Subst Abus. 1989;1(4):471–7.
23.
go back to reference Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstr??M test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict. 1991;86(9):1119–27.CrossRefPubMed Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstr??M test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict. 1991;86(9):1119–27.CrossRefPubMed
24.
go back to reference Nair US, Bell ML, Yuan NP, Wertheim BC, Thomson CA. Associations between comorbid health conditions and quit outcomes among smokers enrolled in a state Quitline, Arizona, 2011–2016. Public Health Rep. 2018;133(2):200–6.CrossRefPubMed Nair US, Bell ML, Yuan NP, Wertheim BC, Thomson CA. Associations between comorbid health conditions and quit outcomes among smokers enrolled in a state Quitline, Arizona, 2011–2016. Public Health Rep. 2018;133(2):200–6.CrossRefPubMed
25.
go back to reference Jung AM, Schweers N, Bell ML, Nair U, Yuan NP. Tobacco use cessation among quitline callers who implemented complete home smoking bans during the quitting process. Prev. Chronic Dis. 2017;26(14):E105. Jung AM, Schweers N, Bell ML, Nair U, Yuan NP. Tobacco use cessation among quitline callers who implemented complete home smoking bans during the quitting process. Prev. Chronic Dis. 2017;26(14):E105.
26.
go back to reference Nair US, Brady B, O’Connor P, Bell ML. Factors predicting client re-enrolment into tobacco cessation services in a state quitline. Prev Chronic Dis. In Press. 2018;15:18_0144. Nair US, Brady B, O’Connor P, Bell ML. Factors predicting client re-enrolment into tobacco cessation services in a state quitline. Prev Chronic Dis. In Press. 2018;15:18_0144.
27.
go back to reference United States Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress A Report of the Surgeon General. A Rep. Surg. Gen. 2014:1081. United States Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress A Report of the Surgeon General. A Rep. Surg. Gen. 2014:1081.
28.
go back to reference North American Quitline Consortium (NAQC). The Minimal Data Set for Evaluating Quitlines. Phoenix, AZ; 2012. North American Quitline Consortium (NAQC). The Minimal Data Set for Evaluating Quitlines. Phoenix, AZ; 2012.
29.
go back to reference Hosmer DW, Lemeshow S. Goodness of fit tests for the multiple logistic regression model. Commun Stat - Theory Methods. 1980;9(10):1043–69.CrossRef Hosmer DW, Lemeshow S. Goodness of fit tests for the multiple logistic regression model. Commun Stat - Theory Methods. 1980;9(10):1043–69.CrossRef
30.
go back to reference Desquilbet L, Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med. 2010;29(9):1037–57.PubMed Desquilbet L, Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med. 2010;29(9):1037–57.PubMed
31.
go back to reference Song G, Landau AS, Gorin TJ, Keithly L. Real-world impact of quitline interventions for provider-referred smokers. Am J Prev Med. 2014;47(4):392–402.CrossRefPubMed Song G, Landau AS, Gorin TJ, Keithly L. Real-world impact of quitline interventions for provider-referred smokers. Am J Prev Med. 2014;47(4):392–402.CrossRefPubMed
32.
go back to reference Willett JG, et al. Clinical faxed referrals to a tobacco Quitline. Reach, enrollment, and participant characteristics. Am J Prev Med. 2009;36(4):337–40.CrossRefPubMed Willett JG, et al. Clinical faxed referrals to a tobacco Quitline. Reach, enrollment, and participant characteristics. Am J Prev Med. 2009;36(4):337–40.CrossRefPubMed
33.
go back to reference Ku L, Bruen BK, Steinmetz E, Bysshe T. Medicaid tobacco cessation: big gaps remain in efforts to get smokers to quit. Health Aff. 2016;35(1):62–70.CrossRef Ku L, Bruen BK, Steinmetz E, Bysshe T. Medicaid tobacco cessation: big gaps remain in efforts to get smokers to quit. Health Aff. 2016;35(1):62–70.CrossRef
34.
go back to reference Patrick DL, Cheadle A, Thompson DC, Diehr P, Koepsell T, Kinne S. The validity of self-reported smoking: a review and meta-analysis. Am J Public Health. 1994;84(7):1086–93.CrossRefPubMedPubMedCentral Patrick DL, Cheadle A, Thompson DC, Diehr P, Koepsell T, Kinne S. The validity of self-reported smoking: a review and meta-analysis. Am J Public Health. 1994;84(7):1086–93.CrossRefPubMedPubMedCentral
Metadata
Title
Quit outcomes among clients ineligible for cessation medication through the state quitline: a retrospective, observational study
Authors
Adrienne B. Lent
Patrick A. O’Connor
Ryan C. Reikowsky
Uma S. Nair
Melanie L. Bell
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2018
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-018-5923-6

Other articles of this Issue 1/2018

BMC Public Health 1/2018 Go to the issue